Skip to content

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-001258-27-DK
Enrollment
Unknown
Registered
2011-05-11
Start date
2011-06-07
Completion date
Unknown
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 13.1 Level: LLT Classification code 10049475 Term: Chronic pain System Organ Class: 10018065 - General disorders and administration site conditions

Interventions

Trade Name: Lidocain "Grunenthal" Pharmaceutical Form: Cutaneous patch Pharmaceutical form of the placebo: Cutaneous patch Route of administration of the placebo: Cutaneous use

Sponsors

Mads Werner
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 15 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 5

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):

Countries

Denmark

Contacts

Public ContactMads Werner

Rigshospitalet

mads.u.werner@gmail.com

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026